Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

2,067 studies match

clinicaltrialsPublishedShowing 501–550 of 2,067 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04502030	Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)	completed	Phase 3	247	OctapharmaINDUSTRY	12	Jun 4, 2026	clinicaltrials
NCT04729387	Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected	terminated	Phase 3	358	Novartis PharmaceuticalsINDUSTRY	26	Jun 4, 2026